LTFS
INDP icon

Ladenburg Thalmann Financial Services’s Indaptus Therapeutics INDP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2
Closed -$38K – 5266
2018
Q4 		$38K Buy
+2
New +$27.3K ﹤0.01% 3441

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ladenburg Thalmann Financial Services's INDP Position: Q1 2019 in Review

Ladenburg Thalmann Financial Services sold out of Indaptus Therapeutics (INDP) in Q1 2019, closing a stake of 2 shares — an estimated $38K sold.

Ladenburg Thalmann Financial Services first reported a position in INDP in Q4 2018 and held it in 1 quarter. The position peaked at $38K in Q4 2018. 36 funds tracked by Wall St. Rank hold INDP as of Q1 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Indaptus Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 2 Indaptus Therapeutics shares in Q1 2019, an estimated $38K.
  • Ladenburg Thalmann Financial Services first reported a position in Indaptus Therapeutics in Q4 2018 and held it in 1 quarter.
  • Ladenburg Thalmann Financial Services's Indaptus Therapeutics position peaked at $38K in Q4 2018.
  • 36 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q1 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2019, filed 15 May 2019.